로딩 중…
지수 로딩 중…
IL DONG PHARMACEUTICAL CO., LTD.
249420· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩16,040-5.26%
2026-06-26
Price Chart
IL DONG PHARMACEUTICAL CO., LTD.+27.10%
Financials
Investment Metrics(as of 2026-06-26)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 507.48B KRW |
| Revenue | 572.95B KRW |
| Net Income | 13.58B KRW |
| Total Assets | 562.10B KRW |
| Net Assets | 239.96B KRW |
| Employees | 1,056 |
| Value | |
| P/E | 37.36x |
| P/B | 2.11x |
| PEG | 0.06x |
| P/S | 0.89x |
| EV/EBITDA | 46.01x |
| FCF Yield | 1.05% |
| Profitability | |
| ROE | 5.66% |
| ROA | 2.42% |
| Op. Margin | 2.26% |
| Revenue Growth | 4.43% |
| Earnings Growth | 617.82% |
| Financial Health | |
| Debt Ratio | 234.25% |
| Total Debt | 124.63B KRW |
| FCF | 5.30B KRW |
| Cash | 35.93B KRW |
| Current Ratio | 0.99x |
| Net Debt/EBITDA | 6.85x |
| Dividend | |
| Div. Yield | 1.18% |
| Performance | |
| 1Y Return | 27.10% |
| 1M Return | -26.76% |
| From 52W High | -64.40% |
| 1Y MDD | -63.79% |
| Trading | |
| Volume | 133,536 shares |
| Foreign Own. | 8.68% |
| Per Share | |
| EPS | 1,143 KRW |
| BPS | 7,863 KRW |
Company Info
Established in 2016, this company manufactures and sells pharmaceuticals, raw materials, and health supplements. Its main products include the active vitamin AROAMIN series and the antibiotic FULUMARIN, which are sold domestically and internationally through various channels. The company conducts R&D for metabolic and respiratory disease treatments, with its COVID-19 treatment ID32124 (Xocova) having received approval in Japan, advancing its global new drug development and commercialization. Ildong Pharmaceutical was founded in 2016 and is headquartered in Seocho-gu, Seoul.